Skip to main content
. 2013 Oct;144(4):1346–1356. doi: 10.1378/chest.12-2396

Figure 1.

Figure 1.

Treatment algorithm for SSc-PAH used in the Johns Hopkins pulmonary hypertension program. 6MWT = 6-min walk test; ERA = endothelin receptor antagonist; FC = functional class; NT-proBNP = N-terminal pro-brain natriuretic peptide; PDE-5I = phosphodiesterase-5 inhibitor; RHC = right-sided heart catheterization; SQ = subcutaneous; SSc-PAH = systemic sclerosis-associated pulmonary arterial hypertension; WHO = World Health Organization.